HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 44 filers reported holding HAEMONETICS CORP MASS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $255,245 | +1.3% | 294,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $251,923 | -91.2% | 294,000 | -91.2% | 0.00% | -92.9% |
Q1 2023 | $2,859,617 | -58.9% | 3,359,000 | -59.8% | 0.01% | -57.6% |
Q4 2022 | $6,963,047 | +4.3% | 8,359,000 | 0.0% | 0.03% | +6.5% |
Q3 2022 | $6,674,000 | +0.8% | 8,359,000 | 0.0% | 0.03% | +6.9% |
Q2 2022 | $6,622,000 | -5.9% | 8,359,000 | 0.0% | 0.03% | +11.5% |
Q1 2022 | $7,037,000 | – | 8,359,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 18,000,000 | $15,705,000 | 1.15% |
Context Capital Management, LLC | 14,558 | $12,660 | 1.02% |
Quaero Capital S.A. | 1,200,000 | $1,042,440 | 0.99% |
READYSTATE ASSET MANAGEMENT LP | 22,200,000 | $19,369,500 | 0.97% |
DeepCurrents Investment Group LLC | 24,371,000 | $21,212,517 | 0.92% |
ADVENT CAPITAL MANAGEMENT /DE/ | 39,904,000 | $34,816,240 | 0.81% |
SSI INVESTMENT MANAGEMENT LLC | 10,872,000 | $9,431,462 | 0.77% |
Empyrean Capital Partners, LP | 13,500,000 | $11,696,959 | 0.72% |
MACKAY SHIELDS LLC | 29,294,000 | $25,825,110 | 0.71% |
Aequim Alternative Investments LP | 20,500,000 | $17,886,250 | 0.68% |